Neuroone Medical Technologies (NMTC) Revenue Growth (3y) (2013 - 2026)
Neuroone Medical Technologies (NMTC) Revenue Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 4.63% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 8.01% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 4.70% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 15.36% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 10.52% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 17.14% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 0.73% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 2.92% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Neuroone Medical Technologies | 7.99 Mn | 5.19 Mn | 990,264.00 | 58.66% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 58.66% |
| Dec 31, 2025 | 193.36% |
| Sep 30, 2025 | 241.56% |
| Jun 30, 2025 | 275.44% |
| Mar 31, 2025 | 235.90% |
| Dec 31, 2024 | 359.50% |
| Sep 30, 2024 | 77.93% |
| Jun 30, 2024 | 174.11% |
| Mar 31, 2024 | 322.67% |
| Dec 31, 2023 | 139.15% |
| Mar 31, 2015 | -8.39% |
| Jun 30, 2014 | -37.11% |
| Mar 31, 2014 | -62.27% |
| Sep 30, 2013 | -2.63% |